A single elevated reading is rarely dangerous. An elevated reading that nobody treats — for months or years — follows a predictable path through the eyes, kidneys, nerves, heart, and feet. Here is that path, stage by stage, and where it can still be interrupted.
Untreated high blood sugar steadily damages blood vessels and nerves. Within weeks it can cause dehydration, infections, and blurred vision; over 5–10 years it drives retinopathy, kidney failure, neuropathy, heart attack, stroke, and amputation. In its most extreme forms — diabetic ketoacidosis or hyperosmolar hyperglycemic state — it can be fatal within days.
- What actually counts as high blood sugar
- One patient's eight-year trajectory: an illustrative case
- How glucose damages tissue at the cellular level
- Complications, organ by organ
- When untreated hyperglycemia becomes an emergency
- Why some people deteriorate faster than others
- What treatment actually changes — and what it can't undo
- The prevention checklist that keeps this trajectory from happening
- Questions people ask about untreated high blood sugar
What Actually Counts as High Blood Sugar
High blood sugar becomes diagnosable at specific numbers, and those numbers matter because the risk of complications climbs continuously as glucose rises — there is no comfortable plateau where damage stops.
The American Diabetes Association's Standards of Care in Diabetes—2026 sets the following diagnostic thresholds:[1]
| Test | Normal | Prediabetes | Diabetes |
|---|---|---|---|
| Fasting plasma glucose | Below 100 mg/dL | 100–125 mg/dL | 126 mg/dL or higher |
| 2-hour glucose (OGTT) | Below 140 mg/dL | 140–199 mg/dL | 200 mg/dL or higher |
| A1C | Below 5.7% | 5.7–6.4% | 6.5% or higher |
| Random glucose with symptoms | — | — | 200 mg/dL or higher |
Two features of these cutoffs catch people off guard. The first is how narrow the gap is between normal and diabetic: fasting glucose moves from 99 to 126 mg/dL, a shift almost nobody can feel. The second is that symptoms typically stay silent until glucose runs consistently above roughly 180 mg/dL — the point at which the kidneys can no longer reabsorb filtered glucose and start dumping it into urine, pulling water and electrolytes along with it.
That silence is the reason "untreated" covers two very different populations: people who have never been diagnosed, and people who were diagnosed but never filled the prescription, stopped it, or fell out of follow-up.
Roughly 38.4 million Americans — about 11.6% of the population — are living with diabetes, and an estimated 8.7 million of them do not know it. Another 97.6 million adults meet the criteria for prediabetes.[2] Diabetes is also the leading cause of kidney failure, non-traumatic lower-limb amputation, and new cases of blindness in adults.[2] Every one of those outcomes begins with glucose that was high and unmanaged.
One Patient's Eight-Year Trajectory: An Illustrative Case
Complication timelines are easier to hold onto when they have a face attached. The case below is not a real person and not a real medical record — it is a composite built from the pattern endocrinologists see repeatedly in clinic.
Daniel spent most of his early fifties mildly thirsty. He woke twice most nights to urinate, assumed it was his prostate, and lost about 12 pounds over a year without trying — which he took as good news. His afternoon vision blurred enough that he stopped reading on his phone. A toenail fungus and a recurring gum infection lingered far longer than they should have. He felt tired, but he had felt tired for years.
A walk-in clinic finally drew an A1C during a bout of bronchitis. It came back at 9.8%. He was handed a metformin prescription and told to follow up in three months. He filled it once. He did not follow up for three years.
The uncomfortable lesson in this timeline is that the loud phase of diabetes — thirst, urination, fatigue — and the harmful phase do not overlap. By the time symptoms are obvious, damage has been accumulating for years.
How Glucose Damages Tissue at the Cellular Level
Glucose at normal concentrations is harmless fuel. Held above roughly 140–180 mg/dL for months, it becomes chemically reactive in ways the body has no built-in defense against. Four pathways run simultaneously, and together they explain why hyperglycemia damages so many different organs with the same underlying signature.
Glycation and advanced glycation end products
Glucose attaches to proteins without an enzyme to guide it. This is the same reaction that produces the A1C measurement — glucose bound to hemoglobin — but it also happens to collagen, LDL cholesterol, and the proteins that form capillary basement membranes. Over years, these cross-linked "advanced glycation end products" stiffen large arteries and thicken small-vessel walls, which is precisely why the retina and glomerulus, whose function depends on thin, precise filtration barriers, fail earlier than other tissues.
The polyol pathway
When intracellular glucose saturates the normal metabolic routes, aldose reductase converts the excess into sorbitol. Sorbitol does not diffuse out of cells easily, so it accumulates and draws water in with it. This osmotic stress is a major contributor to lens opacification and to the metabolic injury of peripheral nerve cells.
Oxidative stress and PKC signaling
High glucose drives mitochondrial overproduction of reactive oxygen species and activates protein kinase C, which increases vascular permeability and raises production of VEGF and endothelin. The result is a vessel wall that leaks, constricts unpredictably, and recruits inflammatory cells.
Low-grade inflammation and a pro-clotting state
Circulating adhesion molecules pull monocytes into the vessel wall, while platelets become more adhesive and clot-dissolving capacity falls. This is the mechanism that links diabetes to atherosclerosis so tightly that diabetes is often described clinically as a cardiovascular risk equivalent.
The organs that fail first in diabetes are not the ones that work hardest. They are the ones whose microvasculature has the least slack — the retina, the glomerulus, and the peripheral nerve.
One consequence of this biology is worth stating plainly: nerve tissue and retinal capillaries do not generate pain signals when they are being damaged. The complication is silent until it is structural.
Complications, Organ by Organ
Every tissue with a dense capillary bed is a target, which is why the complication list for untreated hyperglycemia reads like a tour of the body. What varies is the timeline and how reversible each change is.
| Organ system | What untreated hyperglycemia does | Symptom-free window | Once advanced |
|---|---|---|---|
| Eyes | Capillary occlusion, retinal ischemia, VEGF-driven neovascularization, macular edema, early cataracts | 5–10 years after glucose first rises | Vision loss and blindness; diabetes is a leading cause of new adult blindness[2] |
| Heart and arteries | Accelerated atherosclerosis, endothelial dysfunction, higher plaque instability | Often 10+ years, then presents abruptly | Heart attack, stroke, heart failure; 2–4× higher death risk from heart disease[3] |
| Kidneys | Glomerular hyperfiltration, mesangial expansion, albumin leaking into urine | 2–5 years; detectable only by urine test | Chronic kidney disease in about 1 in 3 adults with diabetes[4], progressing to dialysis |
| Peripheral nerves | Sorbitol accumulation, nerve capillary occlusion, myelin injury | 5–10 years | Numbness, burning pain, loss of protective sensation, falls |
| Autonomic nerves | Damage to nerves governing heart rate, blood pressure, digestion, bladder | Often unnoticed | Silent heart attacks, orthostatic drops, gastroparesis, erectile dysfunction |
| Feet | Neuropathy plus poor perfusion plus impaired immunity | Ulcers appear years after sensation is lost | Non-healing ulcers, osteomyelitis, amputation[2] |
| Brain | Small-vessel disease, inflammation, repeated micro-ischemia | Decade-scale | Vascular cognitive impairment, higher dementia risk, stroke |
| Immune system and gums | Impaired neutrophil function, dry mouth, periodontal inflammation | Immediate — infections last longer from the start | Recurrent infections, severe periodontitis, poor wound healing |
Retinopathy can be present for years before a single symptom appears — and once vision drops from macular edema or a vitreous hemorrhage, treatment restores sight far less reliably. A dilated retinal exam detects it while it is still treatable. That is why the ADA recommends a dilated eye exam at diagnosis for type 2 diabetes and annually thereafter.[1]
When Untreated Hyperglycemia Becomes an Emergency
Everything above unfolds over years. Two conditions unfold over days and can kill a person who was walking around the week before.
Diabetic ketoacidosis (DKA)
DKA happens when there is not enough insulin for glucose to enter cells, so the body burns fat instead and produces acidic ketone bodies. It is most common in type 1 diabetes and can be the first sign of it — particularly in children and young adults — but it also occurs in type 2 diabetes during severe illness or infection. SGLT2 inhibitor medications can trigger a variant with only mildly elevated glucose, so a normal reading does not rule it out.
Hyperosmolar hyperglycemic state (HHS)
HHS typically develops in older adults with type 2 diabetes, often after an infection or a course of steroids. Glucose climbs very high over days, producing profound dehydration and a hyperosmolar bloodstream. Reported mortality for HHS has ranged as high as roughly 20% in some case series,[5] which makes it one of the most dangerous presentations in all of internal medicine.
DKA and HHS are both treatable, and both are largely preventable with insulin, sick-day rules, and monitoring. The deaths that occur with untreated high blood sugar happen disproportionately in people who did not know they had diabetes, or who had no access to the medications they were prescribed.
Why Some People Deteriorate Faster Than Others
Two people can carry the same A1C for a decade and end up in very different places. Glycemia is the engine, but several other variables decide how fast the vehicle moves.
- Duration of exposure. Ten years at an A1C of 7.5% typically inflicts more retinal and kidney injury than three years at 9%.
- Average glucose, not single readings. A1C reflects roughly three months of exposure. Wide swings between highs and lows add oxidative stress on top of it.
- Blood pressure. Hypertension and hyperglycemia damage the same capillaries. When both are present, kidney and retinal decline accelerates.
- Cholesterol and smoking. Smoking amplifies nearly every vascular complication of diabetes and roughly doubles cardiovascular risk on its own.
- Baseline kidney function and genetics. A family history of diabetic kidney disease raises personal risk substantially, independent of glucose control.
- Age at onset. Younger onset means more years of cumulative exposure, which is why early type 2 diagnoses carry higher lifetime complication risk than late ones.
- Access and adherence. Medication cost, insurance gaps, depression, and diabetes-related distress are powerful predictors of outcomes — often stronger than any biological variable in this list.
- Sleep apnea and obesity. Both worsen insulin resistance and raise blood pressure, creating a feedback loop that makes control harder.
If glucose is the only variable being treated, outcomes improve slowly. If blood pressure is brought under 130/80 mmHg[1] and smoking stops, the same A1C produces meaningfully less organ damage. These two changes are inexpensive and produce measurable benefit within months.
What Treatment Actually Changes — and What It Can't Undo
No stage in the timeline above is a one-way door at the moment it happens. Starting treatment late still changes the destination, sometimes dramatically.
The Standards of Care in Diabetes—2026 summarizes decades of randomized trial evidence — including the Diabetes Control and Complications Trial and the UK Prospective Diabetes Study — showing that tighter glycemic control substantially lowers the risk of microvascular complications. In the UKPDS analysis, each 1-percentage-point reduction in A1C was associated with roughly a one-third lower risk of microvascular complications.[1]
| Treatment target | What ADA 2026 recommends for most adults |
|---|---|
| A1C | Below 7%, individualized upward for frailty or hypoglycemia risk, downward when achievable safely[1] |
| Blood pressure | Below 130/80 mmHg[1] |
| Cholesterol | Statin therapy based on overall risk; frequently an LDL target below 70 mg/dL for those with established cardiovascular disease[1] |
| Organ protection | SGLT2 inhibitor or GLP-1 receptor agonist for people with chronic kidney disease, heart failure, or atherosclerotic cardiovascular disease[1] |
| Annual screening | Dilated eye exam, urine albumin-to-creatinine ratio plus eGFR, comprehensive foot exam with sensation testing[1] |
What responds best: newly leaking albumin in the urine, elevated blood pressure, early nerve symptoms, fatty liver changes, and the general trajectory of decline. What does not come back: nephrons destroyed by glomerulosclerosis, retinal tissue lost to ischemia, nerve fibers that have already degenerated, and bone or tissue removed by amputation.
The return on treating hyperglycemia is highest in the first decade, and it is never zero later. Even at an eGFR of 30, adding an SGLT2 inhibitor and controlling blood pressure slows progression to dialysis — it just doesn't reverse it.
The Prevention Checklist That Keeps This Trajectory From Happening
What separates a controlled A1C from a dialysis chair is rarely one dramatic decision. It is a short list of unglamorous items done repeatedly, most of which take less than an hour a year.
Questions People Ask About Untreated High Blood Sugar
Can damage from high blood sugar be reversed?
Some of it, depending on the stage. Early microalbuminuria, elevated blood pressure, fatty liver, and mild nerve symptoms can improve with sustained glucose and blood pressure control. Structural damage does not regenerate — destroyed nephrons, dead retinal capillaries, and amputated tissue are permanent. This is exactly why early treatment gets emphasized so heavily: it is not that diabetes is always aggressive, it is that the window before structural change closes is silent.
How long does it take for high blood sugar to cause damage?
Microvascular damage begins within months of sustained elevation, but clinically detectable complications usually take 5–10 years of poor control. In type 2 diabetes, up to 1 in 5 people already have retinopathy or albuminuria at the moment of diagnosis, because glucose was elevated for years beforehand.[1] In type 1 diabetes, retinopathy rarely appears before five years of disease duration. The acute emergencies — DKA and HHS — can develop in days.
What A1C level is dangerous?
There is no single dangerous threshold, because complication risk rises continuously rather than appearing at a cutoff. That said, an A1C of 9% corresponds to an average glucose of roughly 212 mg/dL, and an A1C above 10% generally warrants prompt treatment intensification, including consideration of insulin. The ADA's diagnostic threshold is 6.5%, and its usual treatment target for nonpregnant adults is below 7%.[1]
What happens if high blood sugar goes untreated for a week?
It depends almost entirely on how high. A week at 150–200 mg/dL typically produces thirst, frequent urination, fatigue, and blurred vision, with no lasting organ damage. A week above 300 mg/dL in someone with little or no insulin production can produce diabetic ketoacidosis within 24–72 hours — dehydration, electrolyte shifts, acid accumulation, and, if untreated, coma. Persistent vomiting, deep rapid breathing, or confusion in anyone with high glucose is a same-day emergency.
Can you have high blood sugar without having diabetes?
Yes. Serious illness or infection, corticosteroid therapy, pancreatitis, Cushing's syndrome, pregnancy, and some antipsychotic medications can all push glucose into diabetic territory temporarily. Steroid-induced hyperglycemia in particular can persist for as long as the steroid is taken and requires active management, not watchful waiting. Anyone with a high reading during illness should be rechecked once they have recovered to see whether the elevation was transient.
Is high blood sugar by itself enough to kill someone?
Rarely in the direct sense, but it is lethal indirectly and often. The mechanisms are severe dehydration and electrolyte derangement in HHS, ketoacidosis in DKA, unchecked infection in a patient whose immune function is impaired, and cardiovascular events driven by years of accelerated atherosclerosis. Diabetes remains among the ten leading causes of death in the United States,[2] and much of that mortality is listed under heart disease or kidney failure rather than diabetes itself.
- Untreated high blood sugar damages the retina, kidney, nerves, heart, and feet through the same underlying mechanism — injury to the smallest blood vessels — and that damage begins months before any symptom appears.
- Clinically detectable complications typically emerge after 5–10 years of poor control, but in type 2 diabetes some people already have retinopathy or protein in the urine at diagnosis.
- Diabetic ketoacidosis and hyperosmolar hyperglycemic state can develop within days and are the two ways untreated hyperglycemia becomes immediately life-threatening.
- Adults with diabetes are 2–4 times more likely to die from heart disease than adults without it, making cardiovascular risk the dominant long-term threat.[3]
- Treatment started late still reshapes the trajectory: ADA 2026 targets are an A1C below 7%, blood pressure below 130/80 mmHg, statin therapy, and an SGLT2 inhibitor or GLP-1 receptor agonist for those with kidney, heart, or cardiovascular disease.[1]
- Annual dilated eye exams, urine albumin testing, and foot checks detect the complications that are still treatable — and nothing detects the ones that are not.
- American Diabetes Association. Standards of Care in Diabetes—2026. Diabetes Care. diabetes.org
- Centers for Disease Control and Prevention. National Diabetes Statistics Report. cdc.gov
- American Heart Association. Diabetes and Cardiovascular Disease. heart.org
- National Institute of Diabetes and Digestive and Kidney Diseases. Diabetic Kidney Disease. niddk.nih.gov
- StatPearls (NCBI Bookshelf). Hyperglycemic Hyperosmolar State and Diabetic Ketoacidosis.
